The ScreenCancer Approach

The ScreenCancer USA proprietary service offerings have been designed with the needs of health plans and self-insured employers in mind.

The ScreenCancer Navigator™ is a multi-channel HIPAA-compliant program that will save costs and significantly increase adherence to screening for major cancers. Applying advanced technology and expertise in cancer screening, ScreenCancer Navigator provides patient education and facilitates cancer screening, thereby reducing costs of advanced cancer treatment, improving member/employee satisfaction, and improving HEDIS scores.

 

Picture1.png

 

 

 

 

 

Despite the dedicated efforts of health care professionals, advocacy groups, and health plans, screening rates still have much room for improvement. To date, two main approaches have been used to increase cancer screening:

  • broad-based education about the benefits of cancer screening;
  • new testing technologies which promise to increase use by those needing cancer screening

Both approaches unfortunately rely on “passive” techniques to encourage people to get screened and demonstrate the difficulty in getting asymptomatic individuals to initiate testing.

The ScreenCancer Navigator uses an “active-management” approach to increase cancer screening rates in a cost-effective manner . Our approach is based on years of experience with cancer screening, strong relationships with testing providers and clinicians, and significant expertise understanding the strengths and weaknesses of various technologies and approaches. When combined with our commitment to high-touch, high quality patient education, patient advocacy and support of approved testing, ScreenCancer is uniquely positioned to change the screening paradigm and save lives.

 

With The Right Intervention, Increases in Adherence to Cancer Screening Recommendations Can Be Achieved

A recent abstract in the American Journal of Gastroenterology demonstrated that a program like the ScreenCancer Navigator can increase colorectal cancer screening compliance from ~20% to ~73%.*

* The American Journal of Gastroenterology, Volume 101, Supplement 2, September 2006 , pp. S545-S561(1)